Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

Share Price is delayed by 15 minutes
Get Live Data
45.00    2.50 (5.88%)
Bid:
44.00
Ask:
46.00
Spread: 2.00 (4.545%)
Market Cap: £86.34m
IOF Live PriceLast checked at - London Stock Exchange

Intraday Iofina Share Chart

Brine Supply Update

23 Nov 2015 07:00

RNS Number : 5415G
Iofina PLC
23 November 2015
 

 

23 November 2015

Iofina plc

("Iofina" or the "Company")

(LSE AIM: IOF)

 

Brine Supply Update

 

Iofina, specialists in the exploration and production of iodine and iodine specialty chemical derivatives, is issuing an update to the market today on the Company's iodine production in the State of Oklahoma.

 

Late last week there was a magnitude 4.7 earthquake with an epicentre approximately 5 miles due south of one of the Company's IOsorb® plants in northwest Oklahoma. There were no injuries to any Iofina employees nor damage to Company facilities. As a result, the Oklahoma Corporation Commission ("OCC") Oil and Gas Conservation Division issued an Implementation Plan to reduce salt water injection in the nearby area. In the coming weeks, the oil and gas producers who own and operate over 20 Salt Water Disposal ("SWD") injection wells in the affected area will likely be reducing injections up to 50% within a 5 mile radius and up to 25% within a 10 mile radius of the affected area at SWDs specified by the OCC. The expected result is anticipated to be a reduction of available brine to IOsorb® plants IO#3 and IO#5 in addition to a possible reduction of brine at plant IO#2. IOsorb® plants IO#4 and IO#6 are not currently affected by this injection reduction plan, but they are located in the area where SWD operational changes could possibly apply at a later date. 

As of today, the ramifications for the Company's iodine production are not certain. The Board is currently estimating that this may reduce Iofina's current production rate of crystalline iodine between 10-20% on a per annum basis from its 5 operating plants.

The Company still anticipates that it will meet H2 production targets of 260-300MT for H2 2015. The Company will be working closely together with its partners to maximize iodine production and revenue. Most of the affected SWD sites where the Company's IOsorb® plants are located are currently injecting volumes in excess of the capacity of Iofina's plants. This was by design to ensure that the Company would have adequate supplies during times of reduced production of brine by the SWD operators. The Company is investigating additional ways to increase water quality and iodine concentrations to improve the overall economics for the Company and its partners.

 

Commenting, President and CEO Tom Becker stated: "While the reduction in brine supply is likely to affect our production at 3 of our 5 IOsorb® plants, we will be working together with our partners to minimize any production losses and together will investigate means to reduce the impact of this decision by the OCC. We are pleased to be on track to meet H2 2015 crystalline iodine production guidance and we intend to provide an update to the market once the impact of this OCC decision is clearer."

 

 

 

 

For further information, please contact:

 

Dr. Tom Becker, CEO & President

Iofina plc

Tel: +44 (0)20 3006 3135

 

Christopher Raggett/Giles Rolls/Joanna Scott

finnCap Ltd

Tel: +44 (0)20 7220 0500

 

Rob Collins/Emily Morris

GMP Securities

Tel: +44(0)20 7647 2800

 

Media Contact:

Dominic Barretto/Harriet Jackson

Yellow Jersey PR Limited

Tel: +44 (0)7768 537 739

About Iofina:

Iofina specializes in the exploration and production of iodine, iodine specialty chemical derivatives and produced water. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America based on Iofina's WET® IOsorb® technology. Iofina has production operations in the United States, specifically in Montana, Kentucky and Oklahoma. It has complete vertical integration from the production of iodine in the field to the manufacture of the chemical end-products derived from iodine to the consumer and the recycling of iodine using iodinated side-streams from waste chemical processes. Iofina utilizes its portfolio of patented and patent pending technology, proprietary methods and trademarks throughout all business lines.

www.iofina.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAEFAAASSFAF
Date   Source Headline
22nd Sep 20219:58 amRNSHolding(s) in Company
10th Sep 20214:15 pmRNSHolding(s) in Company
10th Sep 20213:25 pmRNSHolding(s) in Company
15th Jul 20217:00 amRNSH1 2021 Update
18th Jun 20214:36 pmRNSPrice Monitoring Extension
18th Jun 20213:20 pmRNSResult of AGM
27th May 20214:40 pmRNSSecond Price Monitoring Extn
27th May 20214:36 pmRNSPrice Monitoring Extension
27th May 20212:06 pmRNSSecond Price Monitoring Extn
27th May 20212:00 pmRNSPrice Monitoring Extension
27th May 202111:06 amRNSSecond Price Monitoring Extn
27th May 202111:00 amRNSPrice Monitoring Extension
27th May 20217:00 amRNSHolding(s) in Company
25th May 20217:00 amRNSAnnual Financial Report
21st May 20215:50 pmRNSNotice of Results
15th Apr 20217:00 amRNSQ1 2021 Update
1st Mar 20215:36 pmRNSDirector/PDMR Shareholding
24th Feb 20217:00 amRNSDirector/PDMR Shareholding
19th Feb 20217:00 amRNSDirector/PDMR Shareholding
19th Jan 20217:00 amRNSMarket Update
22nd Dec 20204:41 pmRNSSecond Price Monitoring Extn
22nd Dec 20204:35 pmRNSPrice Monitoring Extension
22nd Dec 20202:05 pmRNSSecond Price Monitoring Extn
22nd Dec 20202:00 pmRNSPrice Monitoring Extension
16th Dec 202011:50 amRNSGrant of Share Options
16th Oct 20207:00 amRNSQ3 2020 Update
13th Oct 20204:40 pmRNSSecond Price Monitoring Extn
13th Oct 20204:35 pmRNSPrice Monitoring Extension
29th Sep 20207:00 amRNSINTERIM RESULTS
23rd Sep 20207:09 amRNSPrice Monitoring Extension
23rd Sep 20207:07 amRNSSecond Price Monitoring Extn
23rd Sep 20207:04 amRNSPrice Monitoring Extension
23rd Sep 20207:01 amRNSSecond Price Monitoring Extn
22nd Sep 20204:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20204:36 pmRNSPrice Monitoring Extension
22nd Sep 20202:05 pmRNSSecond Price Monitoring Extn
22nd Sep 20202:00 pmRNSPrice Monitoring Extension
22nd Sep 20207:00 amRNSDebt Refinancing Signed
26th Aug 20207:00 amRNSDebt Update
31st Jul 20208:00 amRNSLaunch of new website
22nd Jul 202011:06 amRNSSecond Price Monitoring Extn
22nd Jul 202011:00 amRNSPrice Monitoring Extension
22nd Jul 20207:00 amRNSCorporate Update
30th Jun 20202:36 pmRNSDebt Update
30th Jun 202011:52 amRNSResult of AGM
26th Jun 20201:26 pmRNSChange of venue for AGM on 30 June 2020
26th Jun 20207:00 amRNSIO#8 and Debt Update
27th May 20207:00 amRNSFinal Results
19th May 20204:41 pmRNSSecond Price Monitoring Extn
19th May 20204:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.